Search Results

There are 5160 results for: content related to: Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancy

  1. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  2. You have free access to this content
    Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  3. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  4. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Article first published online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  5. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

    European Journal of Pain

    Volume 13, Issue 3, March 2009, Pages: 219–230, Hans G. Kress

    Article first published online : 9 JAN 2012, DOI: 10.1016/j.ejpain.2008.04.011

  6. Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

    Pain Practice

    Volume 10, Issue 5, September/October 2010, Pages: 428–450, Joseph Pergolizzi, Anna Maria Aloisi, Albert Dahan, Joerg Filitz, Richard Langford, Rudolf Likar, Sebastiano Mercadante, Bart Morlion, Robert B. Raffa, Rainer Sabatowski, Paola Sacerdote, Luis M. Torres and Avi A. Weinbroum

    Article first published online : 17 MAY 2010, DOI: 10.1111/j.1533-2500.2010.00378.x

  7. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Article first published online: 8 JUN 2010

  8. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience

    The American Journal on Addictions

    Volume 13, Issue S1, May-June 2004, Pages: S42–S66, Leslie Amass, Walter Ling, Thomas E. Freese, Chris Reiber, Jeffrey J. Annon, Allan J. Cohen, Dennis McCarty, Malcolm S. Reid, Lawrence S. Brown Jr., Cynthia Clark, Douglas M. Ziedonis, Jonathan Krejci, Susan Stine, Theresa Winhusen, Greg Brigham, Dean Babcock, Joan A. Muir, Betty J. Buchan and Terry Horton

    Article first published online : 18 FEB 2010, DOI: 10.1080/10550490490440807

  9. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  10. An injection depot formulation of buprenorphine: extended biodelivery and effects

    Addiction

    Volume 101, Issue 3, March 2006, Pages: 420–432, Stacey C. Sigmon, David E. Moody, Elie S. Nuwayser and George E. Bigelow

    Article first published online : 27 FEB 2006, DOI: 10.1111/j.1360-0443.2006.01348.x

  11. Buprenorphine TTS for children – a review of the drug’s clinical pharmacology

    Pediatric Anesthesia

    Volume 21, Issue 3, March 2011, Pages: 280–290, Erik Michel, Brian J Anderson and Boris Zernikow

    Article first published online : 21 NOV 2010, DOI: 10.1111/j.1460-9592.2010.03437.x

  12. French Field Experience with Buprenorphine

    The American Journal on Addictions

    Volume 13, Issue S1, May-June 2004, Pages: S17–S28, Marc Auriacombe, Mélina Fatséas, Jacques Dubernet, Jean-Pierre Daulouède and Jean Tignol

    Article first published online : 18 FEB 2010, DOI: 10.1080/10550490490440780

  13. The Effects of Cocaine in Buprenorphine-Maintained Outpatient Volunteers

    The American Journal on Addictions

    Volume 3, Issue 2, Spring 1994, Pages: 129–143, Eric C. Strain, Kenzie L. Preston, Maxine L. Stitzer, Ira A. Liebson and George E. Bigelow

    Article first published online : 18 FEB 2010, DOI: 10.1111/j.1521-0391.1994.tb00380.x

  14. Interaction of μ-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice

    European Journal of Pain

    Volume 9, Issue 5, October 2005, Page: 599, Babette Kögel, Thomas Christoph, Wolfgang Straβburger and Elmar Friderichs

    Article first published online : 11 JAN 2012, DOI: 10.1016/j.ejpain.2005.02.002

  15. You have free access to this content
    Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review

    Addiction

    Volume 107, Issue S1, November 2012, Pages: 5–27, Hendrée E. Jones, Sarah H. Heil, Andjela Baewert, Amelia M. Arria, Karol Kaltenbach, Peter R. Martin, Mara G. Coyle, Peter Selby, Susan M. Stine and Gabriele Fischer

    Article first published online : 29 OCT 2012, DOI: 10.1111/j.1360-0443.2012.04035.x

  16. You have free access to this content
    Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Article first published online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  17. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?

    Addiction

    Volume 100, Issue 2, February 2005, Pages: 197–205, Rebecca A. Jenkinson, Nicolas C. Clark, Craig L. Fry and Malcolm Dobbin

    Article first published online : 17 DEC 2004, DOI: 10.1111/j.1360-0443.2004.00958.x

  18. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Article first published online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  19. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm

    Addiction Biology

    Volume 19, Issue 4, July 2014, Pages: 575–586, Sarah F. Cordery, Alistair Taverner, Irna E. Ridzwan, Richard H. Guy, M. Begoña Delgado-Charro, Stephen M. Husbands and Christopher P. Bailey

    Article first published online : 14 DEC 2012, DOI: 10.1111/adb.12020

  20. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

    Addiction

    Volume 102, Issue 4, April 2007, Pages: 616–622, Suzanne Nielsen, Paul Dietze, Nicole Lee, Adrian Dunlop and David Taylor

    Article first published online : 7 FEB 2007, DOI: 10.1111/j.1360-0443.2006.01731.x